首页> 外国专利> 6-CYCLOALKYL-1, 5-DIHYDRO-PYRAZOLO 3,4-D PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A INHIBITORS

6-CYCLOALKYL-1, 5-DIHYDRO-PYRAZOLO 3,4-D PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A INHIBITORS

机译:6-环烷基-1,5-二羟基-吡唑并[3,4-D]嘧啶-4-酮衍生物及其作为PDE9A抑制剂的用途

摘要

The invention relates to novel 6-Cycloalkyl-pyrazolopyrimidinones according to formula (I) wherein R1 is a 5 or 6 membered aromatic heteroaryl-group, R2 is an optional substituent, D is optionally substituted cyclopentyl, cyclohexyl, tetrahydrofuranyl, tetrahydropyranyl or 2-, 3- or 4-pyridyl, m= 1 or 2 and n is 0, 1 or 2. The new compounds are for use as the active entity of medicaments or for the manufacture of medicaments respectively, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. Such conditions may for example be associated with Alzheimers disease, schizophrenia and other diseases. The new compounds are also for example for the manufacture of medicaments and/or for use in the treatment of these diseases, in particular for cognitive impairment associated with such disease. The compounds of the invention show PDE9 inhibiting properties.
机译:本发明涉及根据式(I)的新颖的6-环烷基-吡唑并嘧啶并酮,其中R 1为5或6元芳族杂芳基,R 2为任选的取代基,D为任选取代的环戊基,环己基,四氢呋喃基,四氢吡喃基或2-, 3-或4-吡啶基,m = 1或2,n为0、1或2。新化合物分别用作药物的活性实体或用于制造药物,特别是用于治疗与以下疾病有关的药物感知,专心,学习或记忆力不足。这样的状况可以例如与阿尔茨海默氏病,精神分裂症和其他疾病有关。该新化合物还例如用于制造药物和/或用于治疗这些疾病,特别是用于与这种疾病相关的认知障碍。本发明的化合物显示出PDE9抑制特性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号